Copeptin concentrations during psychological stress: The PsyCo study

European Journal of Endocrinology

Volumn 171, Issue 6, 2014, Pages 737-742

  Siegenthaler, Judith ^a   Walti, Carla ^a   Urwyler, Sandrine Andrea ^a   Schuetz, Philipp ^b   Christ Crain, Mirjam ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Department of Internal Medicine ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COPEPTIN; HYDROCORTISONE; BIOLOGICAL MARKER; GLYCOPEPTIDE;

ADULT; ANXIETY DISORDER; ARTICLE; AVOIDANCE BEHAVIOR; BIOCHEMISTRY; CONTROLLED STUDY; CONVALESCENCE; DISEASE ASSOCIATION; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; OBSERVATIONAL STUDY; PREDICTION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; TENSION; UPREGULATION; BLOOD; BLOOD PRESSURE; CONTROLLED CLINICAL TRIAL; DIABETES INSIPIDUS, NEUROGENIC; HEART RATE; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGY; YOUNG ADULT;

ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; DIABETES INSIPIDUS, NEUROGENIC; FEMALE; GLYCOPEPTIDES; HEART RATE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84911957574     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-14-0405     Document Type: Article

References (26)

1. Morgenthaler NG, Struck J, Alonso C & Bergmann A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clinical Chemistry 2006 52 112-119. (doi:10.1373/clinchem.2005.060038)
2. Balanescu S, Kopp P, Gaskill MB, Morgenthaler NG, Schindler C & Rutishauser J. Correlation of plasma copeptin and vasopressin concentrations in hypo-, iso-, and hyperosmolar States. Journal of Clinical Endocrinology and Metabolism 2011 96 1046-1052. (doi:10.1210/ jc.2010-2499)
3. Szinnai G, Morgenthaler NG, Berneis K, Struck J, Muller B, Keller U & Christ-Crain M. Changes in plasma copeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects. Journal of Clinical Endocrinology and Metabolism 2007 92 3973-3978. (doi:10.1210/jc.2007-0232)
4. Katan M & Christ-Crain M. The stress hormone copeptin: a new prognostic biomarker in acute illness. Swiss Medical Weekly 2010 140 w13101. (doi:10.4414/smw.2010.13101)
5. Robertson GL, Mahr EA, Athar S & Sinha T. Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. Journal of Clinical Investigation 1973 52 2340-2352. (doi:10.1172/JCI107423)
6. Fenske W, Quinkler M, Lorenz D, Zopf K, Haagen U, Papassotiriou J, Pfeiffer AF, Fassnacht M, Stork S & Allolio B. Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome - revisiting the direct and indirect water deprivation tests. Journal of Clinical Endocrinology and Metabolism 2011 96 1506-1515. (doi:10.1210/jc.2010-2345)
7. Katan M, Morgenthaler NG, Dixit KC, Rutishauser J, Brabant GE, Muller B & Christ-Crain M. Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin assay. Journal of Clinical Endocrinology and Metabolism 2007 92 2640-2643. (doi:10.1210/jc.2006-2046)
8. Fenske W, Stork S, Blechschmidt A, Maier SG, Morgenthaler NG & Allolio B. Copeptin in the differential diagnosis of hyponatremia. Journal of Clinical Endocrinology and Metabolism 2009 94 123-129. (doi:10.1210/jc.2008-1426)
9. Tu WJ, Dong X, Zhao SJ, Yang DG & Chen H. Prognostic value of plasma neuroendocrine biomarkers in patients with acute ischaemic stroke. Journal of Neuroendocrinology 2013 25 771-778. (doi:10.1111/jne.12052)
10. Reichlin T, Hochholzer W, Stelzig C, Laule K, Freidank H, Morgenthaler NG, Bergmann A, Potocki M, Noveanu M, Breidthardt T et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction. Journal of the American College of Cardiology 2009 54 60-68. (doi:10.1016/j.jacc.2009.01.076)
11. Darzy KH, Dixit KC, Shalet SM, Morgenthaler NG & Brabant G. Circadian secretion pattern of copeptin, the C-terminal vasopressin precursor fragment. Clinical Chemistry 2010 56 1190-1191. (doi:10.1373/clinchem.2009.141689)
12. Katan M, Muller B & Christ-Crain M. Copeptin: a new and promising diagnostic and prognostic marker. Critical Care 2008 12 117. (doi:10.1186/cc6799)
13. Dickerson SS & Kemeny ME. Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. Psychological Bulletin 2004 130 355-391. (doi:10.1037/0033-2909.130.3.355)
14. Birkett MA. The Trier Social Stress Test protocol for inducing psychological stress. Journal of Visualized Experiments 2011 56 3238. (doi:10.3791/3238)
15. Zerbe RL & Robertson GL. A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria. New England Journal of Medicine 1981 305 1539-1546. (doi:10.1056/NEJM198112243052601)
16. Milles JJ, Spruce B & Baylis PH. A comparison of diagnostic methods to differentiate diabetes insipidus from primary polyuria: a review of 21 patients. Acta Endocrinologica 1983 104 410-416.
17. Kirschbaum C, Pirke KM & Hellhammer DH. The 'Trier Social Stress Test' - a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 1993 28 76-81. (doi:10.1159/000119004)
18. Kelly MM, Tyrka AR, Anderson GM, Price LH & Carpenter LL. Sex differences in emotional and physiological responses to the Trier Social Stress Test. Journal of Behavior Therapy and Experimental Psychiatry 2008 39 87-98. (doi:10.1016/j.jbtep.2007.02.003)
19. Jonsson P, Wallergard M, Osterberg K, Hansen AM, Johansson G & Karlson B. Cardiovascular and cortisol reactivity and habituation to a virtual reality version of the Trier Social Stress Test: a pilot study. Psychoneuroendocrinology 2010 35 1397-1403. (doi:10.1016/j.psyneuen.2010.04.003)
20. Katan M, Morgenthaler N, Widmer I, Puder JJ, Konig C, Muller B & Christ-Crain M. Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level. Neuro Endocrinology Letters 2008 29 341-346.
21. Meyer-Lindenberg A, Domes G, Kirsch P & Heinrichs M. Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nature Reviews. Neuroscience 2011 12 524-538. (doi:10.1038/nrn3044)
22. Tobin VA, Hashimoto H, Wacker DW, Takayanagi Y, Langnaese K, Caquineau C, Noack J, Landgraf R, Onaka T, Leng G et al. An intrinsic vasopressin system in the olfactory bulb is involved in social recognition. Nature 2010 464 413-417. (doi:10.1038/nature08826)
23. Ebstein RP, Israel S, Lerer E, Uzefovsky F, Shalev I, Gritsenko I, Riebold M, Salomon S & Yirmiya N. Arginine vasopressin and oxytocin modulate human social behavior. Annals of the New York Academy of Sciences 2009 1167 87-102. (doi:10.1111/j.1749-6632.2009.04541.x)
24. Donald RA, Alexander SL, Ellis MJ, Evans MJ, Livesey JH & Espiner EA. Regulation of corticotrophin secretion. Clinical Science 1995 88 4-7.
25. Bas F, Darendeliler F, Tatli B, Unal M & Kayserilioglu A. Corticotropin and cortisol response to maximal exercise testing in central diabetes insipidus. Pediatrics International 2007 49 53-57. (doi:10.1111/j.1442-200X.2007.02320.x)
26. Morgenthaler NG, Struck J, Jochberger S & Dunser MW. Copeptin: clinical use of a new biomarker. Trends in Endocrinology and Metabolism 2008 19 43-49. (doi:10.1016/j.tem.2007.11.001)